This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02964/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02964/identifier/pubchem-compound/
n11http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB02964/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB02964/identifier/drugbank/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02964
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB02964 n11:DB02964
dcterms:title
8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One
adms:identifier
n9:46936539 n10:46505703 n12:DB02964 n13:GL4
n3:IUPAC-Name
n4:271B427E-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4284-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4283-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4280-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4281-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4282-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B427C-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B427A-363D-11E5-9242-09173F13E4C5 n4:271B427D-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B427B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B428A-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B428B-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4285-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4286-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4288-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4287-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4289-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4290-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4292-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4293-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B428F-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B428E-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4291-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B427F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B428C-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B428D-363D-11E5-9242-09173F13E4C5